MS

Biogen's MS Pill Roars Out Of Launch Gate

Biogen's MS Pill Roars Out Of Launch Gate

TheStreet.com

Biogen Hits Primary Endpoints in MS Study

Biogen Hits Primary Endpoints in MS Study

Motley Fool

Biogen Idec up after positive MS drug study

Biogen Idec up after positive MS drug study

Marketwatch

Elan completes sale of Tysabri stake to Biogen

Elan completes sale of Tysabri stake to Biogen

Reuters

Tecfidera Raises The Bar For Biogen Idec

Tecfidera Raises The Bar For Biogen Idec

Seeking Alpha

Biogen prices new MS drug at discount to key competitors

Biogen prices new MS drug at discount to key competitors

Reuters

Biogen Reveals Pricing For New MS Drug Tecfidera

Biogen Reveals Pricing For New MS Drug Tecfidera

Forbes

Biogen Wins FDA Approval of MS Pill

Biogen Wins FDA Approval of MS Pill

TheStreet.com

Biogen And The Progress In Multiple Sclerosis Treatment

Biogen And The Progress In Multiple Sclerosis Treatment

Seeking Alpha

Aubagio EU Backing Comes With Generic Worries

Aubagio EU Backing Comes With Generic Worries

Seeking Alpha